Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers. | Front Immunol | 2023 | 38022579 | PubTator, text mining | PubMed |
| The pathogenesis and potential therapeutic targets in sepsis. | MedComm (2020) | 2023 | 38020710 | PubTator, text mining | PubMed |
| From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning. | Mil Med Res | 2023 | 38017571 | PubTator, text mining | PubMed |
| Naringenin Improves Innate Immune Suppression after PRRSV Infection by Reactivating the RIG-I-MAVS Signaling Pathway, Promoting the Production of IFN-I. | Viruses | 2023 | 38005850 | PubTator, text mining | PubMed |
| Pharmacogenomic Analysis of Combined Therapies against Glioblastoma Based on Cell Markers from Single-Cell Sequencing. | Pharmaceuticals (Basel) | 2023 | 38004399 | PubTator, text mining | PubMed |
| Types of Cell Death from a Molecular Perspective. | Biology (Basel) | 2023 | 37998025 | PubTator, text mining | PubMed |
| p97/VCP targets Toxoplasma gondii vacuoles for parasite restriction in interferon-stimulated human cells. | mSphere | 2023 | 37975677 | PubTator, text mining | PubMed |
| The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus. | Int J Mol Sci | 2023 | 37958732 | PubTator, text mining | PubMed |
| Alteration of chromatin high-order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells. | Exploration (Beijing) | 2023 | 37933235 | PubTator, text mining | PubMed |
| Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin. | Nat Commun | 2023 | 37925520 | PubTator, text mining | PubMed |
| Integrative modeling of guanylate binding protein dimers. | Protein Sci | 2023 | 37916607 | PubTator, text mining | PubMed |
| Quantifying the impact of immunotherapy on RNA dynamics in cancer. | J Immunother Cancer | 2023 | 37914385 | PubTator, text mining | PubMed |
| Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, autophagy, and YB-1 independent manner. | PLoS One | 2023 | 37910521 | PubTator, text mining | PubMed |
| CAR Gene Delivery by T-cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms. | Adv Sci (Weinh) | 2023 | 37904721 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death? | Biomedicines | 2023 | 37893166 | PubTator, text mining | PubMed |
| Comprehensive analyses identify potential biomarkers for encephalitis in HIV infection. | Sci Rep | 2023 | 37891420 | PubTator, text mining | PubMed |
| New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival. | Sci Rep | 2023 | 37880378 | PubTator, text mining | PubMed |
| Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer. | Anal Cell Pathol (Amst) | 2023 | 37868825 | PubTator, text mining | PubMed |
| Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics. | Circulation | 2023 | 37850387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=10